🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 1/2, open label, single-center study designed to assess the...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-20
Trial ID
NCT05581875
Treatments Being Tested
This is a phase 1/2, open label, study designed to assess the safety and cl...
Status
Unknown
Location
Department of Clinical Therapeutics, School of Medicine, National Kapodistrian University of Athens (NKUA)
Start Date
2022-04-13
Trial ID
NCT05280275
Treatments Being Tested
This phase II trial investigates the effect of belantamab mafodotin and len...
Status
Active Not Recruiting
Location
Roswell Park Cancer Institute
Start Date
2024-08-19
Trial ID
NCT04876248
Treatments Being Tested
This is a phase 1/2, open-label study designed to assess the safety and cli...
Status
Recruiting
Location
General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic
Start Date
2023-07-14
Trial ID
NCT05573802
Treatments Being Tested
This phase II trial tests alternate doses and dosing schedules of belantama...
Status
Recruiting
Location
Mayo Clinic in Florida
Start Date
2024-01-04
Trial ID
NCT05847569
This phase II trial studies the effect of belantamab mafodotin, pomalidomid...
Status
Recruiting
Location
Emory University/Winship Cancer Institute
Start Date
2022-07-21
Trial ID
NCT05208307
Treatments Being Tested
The purpose of this study is to describe the real-world use of Belantamab M...
Status
Completed
Location
Duke University Medical Center
Start Date
2023-09-18
Trial ID
NCT05986682
Treatments Being Tested
This phase I/II trial studies the best dose and effect of belantamab mafodo...
Status
Terminated
Location
Mayo Clinic in Rochester
Start Date
2021-06-03
Trial ID
NCT04892264
This is a phase 1/2, open label, study designed to assess the safety and cl...
Status
Active Not Recruiting
Location
General Hospital of Athens "Alexandra"
Start Date
2021-02-22
Trial ID
NCT04808037
Treatments Being Tested